Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation

Lignende værker

• Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and post-pazopanib era: a meta-analytic evaluation
  af: Kazuhiro Tanaka, et al.
  Udgivet: (2019-01-01)
• Surrogate endpoints for overall survival in randomised controlled trials of localised osteosarcoma: A meta-analytic evaluation
  af: Tanaka, Kazuhiro, et al.
  Udgivet: (2020)
• A meta-analytic evaluation of the correlation between event-free survival and overall survival in randomized controlled trials of newly diagnosed Ewing sarcoma
  af: Tanaka, Kazuhiro, et al.
  Udgivet: (2020)
• A meta-analysis of randomized controlled trials that compare standard doxorubicin with other first-line chemotherapies for advanced/metastatic soft tissue sarcomas
  af: Tanaka, Kazuhiro, et al.
  Udgivet: (2019)
• MicroRNA-181c prevents apoptosis by targeting of FAS receptor in Ewing’s sarcoma cells
  af: Kawano, Masanori, et al.
  Udgivet: (2018)